Showing results (1621-1630 of 1,766) with videos related to
Sort By:
Pageof 177
Cellular & Molecular Immunology|September 7, 2022
S1P/S1PR1 signaling differentially regulates the allogeneic response of CD4 and CD8 T cells by modulating mitochondrial fissionLinlu Tian, Yongxia Wu, Hee-Jin Choi, et al.Cellular & Molecular Immunology|January 19, 2021
Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factorsKoji Onomoto, Kazuhide Onoguchi, Mitsutoshi YoneyamaCellular & Molecular Immunology|November 16, 2021
Homeoprotein SIX1 compromises antitumor immunity through TGF-β-mediated regulation of collagensWancheng Liu, Meiling Gao, Lili Li, et al.Cellular & Molecular Immunology|November 17, 2021
The membrane-associated E3 ubiquitin ligase MARCH3 downregulates the IL-6 receptor and suppresses colitis-associated carcinogenesisHeng Lin, Lu Feng, Kai-Sa Cui, et al.Cellular & Molecular Immunology|January 12, 2022
Reprogramming cholesterol metabolism in macrophages and its role in host defense against cholesterol-dependent cytolysinsMin-Sub Lee, Steven J BensingerCellular & Molecular Immunology|January 12, 2022
Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantationXu-Ying Pei, Xue-Fei Liu, Xiang-Yu Zhao, et al.Cellular & Molecular Immunology|January 18, 2022
Downregulated cytotoxic CD8+ T-cell identifies with the NKG2A-soluble HLA-E axis as a predictive biomarker and potential therapeutic target in keloidsHeng Xu, Zhu Zhu, Jian Hu, et al.Cellular & Molecular Immunology|January 19, 2022
The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapyXiaohu Zheng, Yaqi Wu, Jiacheng Bi, et al.Cellular & Molecular Immunology|November 23, 2021
STING signaling activation inhibits HBV replication and attenuates the severity of liver injury and HBV-induced fibrosisYuqi Li, Minjing He, Ziyu Wang, et al.Cellular & Molecular Immunology|January 5, 2022
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primatesStéphane Pillet, Prabhu S Arunachalam, Guadalupe Andreani, et al.Pageof 177